We sincerely appreciate the support of our valued partners in making Cell & Gene Therapy Manufacturing 2025 a tremendous success. As part of IMAPAC’s commitment to serving all event stakeholders, we are pleased to share this post-event report.

This year’s event brought together world-class expert speakers and industry leaders in CGT. We greatly appreciate the valuable feedback received from participants, and we are delighted that a significant number of attendees found the event to be informative, needs-driven, and an excellent platform for networking with the right professionals.

With your continued support, we are confident in expanding and enhancing next year’s event by incorporating the insights gathered.

We eagerly look forward to hosting CGT Manufacturing DACH 2026 and delivering an even more impactful experience.

Once again, thank you to all our partners for contributing to the event’s success.

Yours sincerely, Tim Richters, Director of Commercial Strategy